Assay Procedure for the MTB/RIF Test. Two volumes of sample treatment... | Download Scientific Diagram
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study | BMC Infectious Diseases | Full Text
Molbio Diagnostics Pvt. Ltd.
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid | Thorax
Comprehensive gene profiling, molecular tumor board (mtb) and artificial intelligence in the diagnosis and treatment of patients with rare adult cancers – EJP RD – European Joint Programme on Rare Diseases
Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia | PNAS
Summary of HIV-MTB co-infection and treatment scenarios. | Download Table
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study | Scientific Reports
![PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b2748c6b14c22d792915b1e9fc3db2be946ae59/3-Figure2-1.png "PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar")
PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar
Diagnostic biomarkers for active tuberculosis: progress and challenges | EMBO Molecular Medicine
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine
Frontiers | Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments | Science Advances
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 | SpringerLink
Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis – TB DIAH
Tuberculosis Drug Discovery: Challenges and New Horizons | Journal of Medicinal Chemistry
Tuberculosis: Past, present and future of the treatment and drug discovery research - ScienceDirect
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test | aidsmap
Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
Figure 3 - Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia - Volume 22, Number 3—March 2016 - Emerging Infectious Diseases journal - CDC
Therapeutic host-directed strategies to improve outcome in tuberculosis | Mucosal Immunology
Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine
